METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY

Clinical trials for METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New score could help guide Late-Stage breast cancer treatment decisions

Knowledge-focused Completed

This study aims to create and test a scoring system that helps doctors identify which patients with metastatic breast cancer are likely to live longer with a third round of chemotherapy. Researchers will collect information from 267 women, including standard tests and a newer tes…

Matched conditions: METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY

Phase: PHASE4 • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused

Last updated May 17, 2026 04:11 UTC

METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY

Get alerted when new METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY trials appear

New score could help guide Late-Stage breast cancer treatment decisions